Cencora (COR) Debt/Assets Ratio: History & Chart

Cencora, Inc. (COR)CORCencora, Inc.

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA

51,000 employees

www.cencora.com

Healthcare / Medical - Distribution

Sector: Healthcare
Industry: Medical - Distribution
CEO: Robert Mauch

View full financials

COR Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

15.17%

DEBT TO ASSETS RATIO AVG TTM

12.30%

DEBT TO ASSETS RATIO AVG 3Y

10.26%

DEBT TO ASSETS RATIO AVG 5Y

11.02%

DEBT TO ASSETS RATIO AVG 10Y

11.80%

DEBT TO ASSETS RATIO AVG 15Y

11.14%

DEBT TO ASSETS RATIO AVG 20Y

10.72%

CURRENT VS TTM AVG

+23.35%

CURRENT VS 3Y AVG

+47.83%

CURRENT VS 5Y AVG

+37.67%

CURRENT VS 10Y AVG

+28.57%

CURRENT VS 15Y AVG

+36.14%

CURRENT VS 20Y AVG

+41.56%

SECTOR MEDIAN · HEALTHCARE

0.29%

median of 79 covered companies

CURRENT VS SECTOR MEDIAN

+5130.57%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
Cencora, Inc. (COR)	$62.18B	15.17%	12.30%	10.26%	11.02%
Becton, Dickinson and Company (BDX)vs ›	$60.26B	0.35%	N/A	N/A	N/A
Boston Scientific Corporation (BSX)vs ›	$68.46B	0.28%	N/A	N/A	N/A
Cardinal Health, Inc. (CAH)vs ›	$54.46B	0.18%	N/A	N/A	N/A
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$71.62B	0.07%	N/A	N/A	N/A
Edwards Lifesciences Corporation (EW)vs ›	$48.18B	0.05%	N/A	N/A	N/A
Humana Inc. (HUM)vs ›	$46.67B	0.27%	N/A	N/A	N/A
IDEXX Laboratories, Inc. (IDXX)vs ›	$44.93B	0.32%	N/A	N/A	N/A
Cigna Corporation (CI)vs ›	$79.64B	0.20%	N/A	N/A	N/A
Elevance Health Inc. (ELV)vs ›	$83.65B	0.27%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

Cencora, Inc. (COR)

$62.18B

15.17%

12.30%

10.26%

11.02%

Becton, Dickinson and Company (BDX)vs ›

$60.26B

0.35%

N/A

Boston Scientific Corporation (BSX)vs ›

$68.46B

0.28%

N/A

Cardinal Health, Inc. (CAH)vs ›

$54.46B

0.18%

N/A

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$71.62B

0.07%

N/A

Edwards Lifesciences Corporation (EW)vs ›

$48.18B

0.05%

N/A

Humana Inc. (HUM)vs ›

$46.67B

0.27%

N/A

IDEXX Laboratories, Inc. (IDXX)vs ›

$44.93B

0.32%

N/A

Cigna Corporation (CI)vs ›

$79.64B

0.20%

N/A

Elevance Health Inc. (ELV)vs ›

$83.65B

0.27%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for Cencora, Inc. (COR)?

The debt to assets ratio for COR stock is 15.17%.

Is Cencora, Inc.'s debt to assets ratio high or low?

The debt to assets ratio of 15.17% is 38% above its 5-year average of 11.02%, near the high end of its 5-year range (7.09%–15.26%).

What is the TTM average debt to assets ratio for Cencora, Inc. (COR)?

The TTM average debt to assets ratio for COR stock is 12.30%.

What is the 3Y average debt to assets ratio for Cencora, Inc. (COR)?

The 3Y average debt to assets ratio for COR stock is 10.26%.

What is the 5Y average debt to assets ratio for Cencora, Inc. (COR)?

The 5Y average debt to assets ratio for COR stock is 11.02%.

What is the 10Y average debt to assets ratio for Cencora, Inc. (COR)?

The 10Y average debt to assets ratio for COR stock is 11.80%.

What is the 15Y average debt to assets ratio for Cencora, Inc. (COR)?

The 15Y average debt to assets ratio for COR stock is 11.14%.

What is the 20Y average debt to assets ratio for Cencora, Inc. (COR)?

The 20Y average debt to assets ratio for COR stock is 10.72%.

DATE	DEBT TO ASSETS RATIO
2026-03-31	15.17%
2025-12-31	10.11%
2025-09-30	14.03%
2025-06-30	11.14%
2025-03-31	11.03%
2024-12-31	11.80%
2024-09-30	9.91%
2024-06-30	7.09%
2024-03-31	8.22%
2023-12-31	7.39%
2023-09-30	10.90%
2023-06-30	8.21%
2023-03-31	8.39%
2022-12-31	9.75%
2022-09-30	13.42%
2022-06-30	10.60%
2022-03-31	11.27%
2021-12-31	11.60%
2021-09-30	15.26%
2021-06-30	12.70%
2021-03-31	13.39%
2020-12-31	8.36%
2020-09-30	11.25%
2020-06-30	12.47%
2020-03-31	12.13%
2019-12-31	12.86%
2019-09-30	11.47%
2019-06-30	11.71%
2019-03-31	11.96%
2018-12-31	11.90%
2018-09-30	12.38%
2018-06-30	12.44%
2018-03-31	12.74%
2017-12-31	12.75%
2017-09-30	10.74%
2017-06-30	10.92%
2017-03-31	12.95%
2016-12-31	13.21%
2016-09-30	13.32%
2016-06-30	13.81%
2016-03-31	13.81%
2015-12-31	14.64%
2015-09-30	12.59%
2015-06-30	13.72%
2015-03-31	14.84%
2014-12-31	8.01%
2014-09-30	9.27%
2014-06-30	9.67%
2014-03-31	6.86%
2013-12-31	9.19%
2013-09-30	7.38%
2013-06-30	8.42%
2013-03-31	8.67%
2012-12-31	9.01%
2012-09-30	9.37%
2012-06-30	11.91%
2012-03-31	12.03%
2011-12-31	12.07%
2011-09-30	9.11%
2011-06-30	9.17%
2011-03-31	9.15%
2010-12-31	9.93%
2010-09-30	9.31%
2010-06-30	9.71%
2010-03-31	9.83%
2009-12-31	10.15%
2009-09-30	8.68%
2009-06-30	9.35%
2009-03-31	9.24%
2008-12-31	9.45%
2008-09-30	9.73%
2008-06-30	10.29%
2008-03-31	9.75%
2007-12-31	9.93%
2007-09-30	9.97%
2007-06-30	9.41%
2007-03-31	8.83%
2006-12-31	9.29%
2006-09-30	8.57%
2006-06-30	8.43%
2006-03-31	8.45%
2005-12-31	8.37%
2005-09-30	8.37%
2005-06-30	7.52%
2005-03-31	8.23%
2004-12-31	10.83%
2004-09-30	12.34%
2004-06-30	11.89%
2004-03-31	14.12%
2003-12-31	14.99%
2003-09-30	14.82%
2003-06-30	18.24%
2003-03-31	16.73%
2002-12-31	18.42%
2002-09-30	16.21%
2002-06-30	14.75%

DATE

DEBT TO ASSETS RATIO

2026-03-31

15.17%

2025-12-31

10.11%

2025-09-30

14.03%

2025-06-30

11.14%

2025-03-31

11.03%

2024-12-31

11.80%

2024-09-30

9.91%

2024-06-30

7.09%

2024-03-31

8.22%

2023-12-31

7.39%

2023-09-30

10.90%

2023-06-30

8.21%

2023-03-31

8.39%

2022-12-31

9.75%

2022-09-30

13.42%

2022-06-30

10.60%

2022-03-31

11.27%

2021-12-31

11.60%

2021-09-30

15.26%

2021-06-30

12.70%

2021-03-31

13.39%

2020-12-31

8.36%

2020-09-30

11.25%

2020-06-30

12.47%

2020-03-31

12.13%

2019-12-31

12.86%

2019-09-30

11.47%

2019-06-30

11.71%

2019-03-31

11.96%

2018-12-31

11.90%

2018-09-30

12.38%

2018-06-30

12.44%

2018-03-31

12.74%

2017-12-31

12.75%

2017-09-30

10.74%

2017-06-30

10.92%

2017-03-31

12.95%

2016-12-31

13.21%

2016-09-30

13.32%

2016-06-30

13.81%

2016-03-31

13.81%

2015-12-31

14.64%

2015-09-30

12.59%

2015-06-30

13.72%

2015-03-31

14.84%

2014-12-31

8.01%

2014-09-30

9.27%

2014-06-30

9.67%

2014-03-31

6.86%

2013-12-31

9.19%

2013-09-30

7.38%

2013-06-30

8.42%

2013-03-31

8.67%

2012-12-31

9.01%

2012-09-30

9.37%

2012-06-30

11.91%

2012-03-31

12.03%

2011-12-31

12.07%

2011-09-30

9.11%

2011-06-30

9.17%

2011-03-31

9.15%

2010-12-31

9.93%

2010-09-30

9.31%

2010-06-30

9.71%

2010-03-31

9.83%

2009-12-31

10.15%

2009-09-30

8.68%

2009-06-30

9.35%

2009-03-31

9.24%

2008-12-31

9.45%

2008-09-30

9.73%

2008-06-30

10.29%

2008-03-31

9.75%

2007-12-31

9.93%

2007-09-30

9.97%

2007-06-30

9.41%

2007-03-31

8.83%

2006-12-31

9.29%

2006-09-30

8.57%

2006-06-30

8.43%

2006-03-31

8.45%

2005-12-31

8.37%

2005-09-30

8.37%

2005-06-30

7.52%

2005-03-31

8.23%

2004-12-31

10.83%

2004-09-30

12.34%

2004-06-30

11.89%

2004-03-31

14.12%

2003-12-31

14.99%

2003-09-30

14.82%

2003-06-30

18.24%

2003-03-31

16.73%

2002-12-31

18.42%

2002-09-30

16.21%

2002-06-30

14.75%

Debt to Assets Ratio: 15.17%

COR Debt to Assets Ratio

COR Average Debt to Assets Ratio Chart

COR Current vs Average Debt to Assets Ratio Chart

COR Debt to Assets Ratio Metrics

COR Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

COR Debt to Assets Ratio History

Related Metrics